Prostate Cancer - Results from #900

REVIEW UroToday

The promotion of cell migration and anoikis resistance by Rad9 contributes to prostate tumor progression, "Beyond the Abstract," by Constantinos G. Broustas and Howard B. Lieberman May 21, 2013

"Beyond the Abstract," Overview of randomized controlled treatment trials for clinically localized prostate cancer: Implications for active surveillance and the United States Preventative Task Force report on screening, by Mack Roach III, MD, FACR May 17, 2013

"Beyond the Abstract," Genitourinary malignancy presenting as an ocular metastasis: A case report and review of the literature, by Shilo Lefresne, MD and Alysa Fairchild MD, FRCPC May 15, 2013

Current standards and future directions for prostate cancer radiation therapy, "Beyond the Abstract," by Michael Pinkawa, MD May 4, 2013

The prostate cancer screening controversy: Addressing bioethical concerns at a community health promotion event for men, "Beyond the Abstract," by Jenna L. Davis, MPH, Brian M. Rivers, PhD, MPH, and B. Lee Green, PhD May 1, 2013

Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy, "Beyond the Abstract," by Helene Hartvedt Grytli and Kristin Austlid Taskén April 25, 2013

Outcomes of salvage prostate cryotherapy stratified by pre-treatment PSA: Update from the COLD registry, "Beyond the Abstract," by Philippe E. Spiess, MD, MSc, FACS, FRCS(C) April 19, 2013

Enhancing the effectiveness of androgen deprivation in prostate cancer by inducing Filamin A nuclear localization, "Beyond the Abstract," by Paramita M Ghosh, PhD, et al April 18, 2013

Testing for the recurrent HOXB13 G84E germline mutation in men with clinical indications for prostate biopsy, "Beyond the Abstract," by Florian R. Schroeck, MD, MS and John T. Wei, MD, MS April 17, 2013

Pitfalls with (18)F-Choline PET/CT in patients with prostate cancer, "Beyond the Abstract," by A.M. García Vicente April 16, 2013

Targeted biopsy based on ADC map in the detection and localization of prostate cancer: A feasibility study, "Beyond the Abstract," by Yuji Watanabe, MD, PhD April 15, 2013

Diethylstilbestrol in castration-resistant prostate cancer, "Beyond the Abstract," by Anna Wilkins April 12, 2013

Functional characterization of circulating tumor cells with a prostate-cancer-specific microfluidic device, "Beyond the Abstract," by Steven M. Santana and Brian J. Kirby April 11, 2013

Analysis of the randomized phase 3 clinical trials in men with castration-resistant prostate cancer indicates sipuleucel-T immune parameters correlate with survival, "Beyond the Abstract," by Mayer N. Fishman, MD, PhD, et al April 10, 2013

Prospective study on metabolic factors and risk of prostate cancer, "Beyond the Abstract," by Christel Häggström, Tanja Stocks, and Pär Stattin April 5, 2013

Optimizing the use of [11C]Choline positron emission tomography/computerized tomography for detecting recurrance of prostate cancer: Determining the best patient candidates, "Beyond the Abstract," by Margarita Kirienko and Maria Picchio April 3, 2013

Exosomes as biomarker enriched microvesicles: Characterization of exosomal proteins derived from a panel of prostate cell lines with distinct AR phenotypes, "Beyond the Abstract," by Emma S. Tomlinson Guns, PhD and Elham Hosseini-Beheshti, PhD candidate April 2, 2013

How reliable are "reputable sources" for medical information on the Internet? The case of hormonal therapy to treat prostate cancer, "Beyond the Abstract," by Richard Wassersug, PhD April 2, 2013

Folate intake, alcohol consumption, and the methylenetetrahydrofolate reductase (MTHFR) C677T gene polymorphism: Influence on prostate cancer risk and interactions, "Beyond the Abstract," by Lindsay Kobayashi and Kristan J. Aronson, PhD March 28, 2013

Impact of androgen deprivation therapy on weight gain differs by age in men with nonmetastatic prostate cancer, "Beyond the Abstract," by Narhari Timilshina and Shabbir M.H. Alibhai March 27, 2013

Page 46 of 57